Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.
about
Alzheimer's disease: experimental models and reality.Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Small-molecule PET Tracers for Imaging Proteinopathies.
P2860
Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evolution of neurodegeneration ...... he Alzheimer disease spectrum.
@en
type
label
Evolution of neurodegeneration ...... he Alzheimer disease spectrum.
@en
prefLabel
Evolution of neurodegeneration ...... he Alzheimer disease spectrum.
@en
P2093
P2860
P50
P1476
Evolution of neurodegeneration ...... he Alzheimer disease spectrum.
@en
P2093
Bradley F Boeve
David T Jones
Emily S Lundt
Jeffrey L Gunter
Mary M Machulda
Matthew L Senjem
Michelle M Mielke
Prashanthi Vemuri
Rosebud O Roberts
Stephen D Weigand
P2860
P356
10.1016/J.NEUROBIOLAGING.2016.06.003
P577
2016-06-16T00:00:00Z